CervoMed Inc. (CRVO)
NASDAQ: CRVO · IEX Real-Time Price · USD
14.03
-0.34 (-2.37%)
At close: Jul 26, 2024, 4:00 PM
14.02
-0.01 (-0.07%)
After-hours: Jul 26, 2024, 7:23 PM EDT
CervoMed Revenue
CervoMed had revenue of $2.35M in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $8.08M. In the year 2023, CervoMed had annual revenue of $7.14M.
Revenue (ttm)
$8.08M
Revenue Growth
+352.05%
P/S Ratio
18.20
Revenue / Employee
$795,539
Employees
8
Market Cap
115.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.14M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCRVO News
- 9 days ago - CervoMed to Participate in the Emerging Growth Conference - GlobeNewsWire
- 15 days ago - CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024 - GlobeNewsWire
- 6 weeks ago - CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies - GlobeNewsWire
- 2 months ago - CervoMed to Appoint William Elder as Chief Financial Officer - GlobeNewsWire
- 2 months ago - CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - CervoMed to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors - GlobeNewsWire